The American Diabetes Association (ADA) wants to help you understand time in range (TIR) as a new blood glucose management measure and implement it with the appropriate patients today.
For many people with diabetes, blood glucose monitoring is key for achieving glycemic targets. Self-monitoring of blood glucose is an integral component of effective therapy of patients taking insulin. In recent years, continuous glucose monitoring (CGM) has emerged as a complementary method for assessing blood glucose levels. CGM accuracy and affordability has evolved rapidly and many patients have these data available to assist with both self-management and assessment by providers. Reports can be generated from CGM that will allow the provider to assess hypoglycemia, hyperglycemia, and glycemic variability plus determine TIR.
A consensus document highlighted the type of report that can be generated (1). (See Fig. 6.1 from the ADA’s Standards of Medical Care in Diabetes shown above). Published data suggest a strong correlation between TIR and A1C, with a goal of 70% TIR aligning with an A1C of ∼7% in two prospective studies (2, 3).
The ADA’s Time in Range initiative will provide guidance on treating your patients with diabetes who might benefit from time in range. Visit the Institute of Learning for TIR webinars, podcast episodes, and practice pearl videos.
Access Time in Range Resources
Time in Range Challenge: Standards of Care
Test your knowledge in this Time in Range FREE case study competition.
Sharpen your skills with these quick case study exercises and earn points, have fun, learn something new and discover relevant resources that can support your practice.
Latest Webinars
2023 ADA Standards of Care: Diabetes Technology Update
March 1, 2023 at 4 pm ET
The Standards of Care in Diabetes (SOC) includes all of ADA’s current clinical practice recommendations and is intended to provide clinicians, patients, researchers, payers, and others with the components of diabetes care, general treatment goals, and tools to evaluate the quality of care. The recommendations are based on an extensive review of the clinical diabetes literature, supplemented with input from ADA staff and the medical community at large. This webinar will discuss the latest guidelines that pertain to diabetes technology/ TIR and address how the 2023 recommendations can be implemented in clinic.
Speaker(s):
Viral Shah, MD - Barbara Davis Center for Diabetes
Grazia Aleppo, MD, FACE, FACP – Northwestern University
Moderator: Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP – Cleveland Clinic
Recording coming soon!
Time in Range: Workflow
November 9, 2022 at 4 pm ET
Join Anastasia Albanese-O'Neill, ARNP, PhD, CDE, Jennie Votta, DNP, NP-C, and Amanda Sheehan, NP as they discuss workflow and how healthcare teams can efficiently incorporate diabetes technology into their practice to optimize time with patients.
Log in or create a FREE account to view recording!
Time in Range: Reducing Barriers
September 27, 2022 at 4 pm ET
Join Dr. Monica Peek and Dr. Anne Peters as they discuss the barriers that prevent or delay healthcare professionals from utilizing diabetes technology and CGM metrics, such as time in range, to treat patients. They will review the use of various diabetes technologies to achieve time in range and provide insight on how they overcame barriers within their practice that serves diverse populations.
Log in or create a FREE account to view recording!
Webinar Recording Library
Did you miss a webinar opportunity? Do you want to rewatch an informative presentation from diabetes experts from around the world? View the archived recorded webinar presentations.
TIR Recorded Webinars : To view past webinars related to Time in Range.
Professional Webinars: To view ADA Professional member-only webinars. Diabetes experts from around the world presented educational webinars, and many of these webinars were sponsored by the ADA Professional Interest Groups. These webinars have been developed by your peers in the ADA's Professional Membership Interest Groups.
Related Programs
Making Diabetes Technology Work
*CE Credit Available*
Learn how to incorporate cutting-edge diabetes technologies into your practice by enhancing your knowledge of available diabetes technologies and matching patients to the right technology so that they can reach their targets.
Other ADA Resources
Education Recognition Programs
References
- Battelino T. et al. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care 2019;42:1593–1603
- Vigersky RA, McMahon C. The relationship of hemoglobin A1C to time-in-range in patients with diabetes. Diabetes Technol Ther 2019;21:81–85
- Beck RW, Bergenstal RM, Cheng P, et al. The relationships between time in range, hyperglycemia metrics, and HbA1c. J Diabetes Sci Technol 2019;13:614–62
- Diabetes Care 2023;46(Supplement_1):S97–S110
The ADA's Time in Range initiative is supported by:
